Bullish
Johnson & Johnson (JNJ) is prioritizing cancer and neuroscience for long-term growth and aims to be the leading cancer company by 2030, following an a...
Neutral
Johnson & Johnson (JNJ) stock has shown remarkable independence from the S&P 500, with a low correlation of 0.18 over the past five years, making it a...
Bullish
DePuy Synthes, Johnson & Johnson's orthopedics business, has appointed Christina Zamarro as its new CFO in anticipation of its planned separation from...
Neutral
Johnson & Johnson's DePuy Synthes Orthopaedics business has appointed Christina Zamarro as its new CFO, effective July 13, 2026. Zamarro brings over 2...
Neutral
Welch Group LLC cut its stake in shares of Johnson & Johnson (NYSE:JNJ – Free Report) by 5.5% in the 1st quarter, according to the company in its most...
Neutral
Johnson & Johnson (JNJ) successfully defended itself against a lawsuit where a Los Angeles jury found the company not negligent in claims that its tal...
Neutral
Louisiana State Employees Retirement System acquired a new stake in Johnson & Johnson (NYSE:JNJ – Free Report) during the first quarter, according to ...
Neutral
Johnson & Johnson (JNJ) CEO Joaquin Duato has announced the company will not enter the lucrative obesity drug market, choosing instead to focus on bec...
Bullish
Johnson & Johnson is investing over $1 billion to construct a new contact lens manufacturing plant in Jacksonville, Florida. This facility, part of a ...
Bearish
A Los Angeles jury awarded $32 million to the family of a woman who died of mesothelioma, finding that decades of using Johnson’s Baby Powder was a su...
Bullish
Johnson & Johnson (JNJ) stock rose by 3.07% on June 23, driven by institutional investors seeking defensive exposure and the company's strong earnings...
Neutral
AEGON ASSET MANAGEMENT UK Plc lowered its holdings in shares of Johnson & Johnson (NYSE:JNJ – Free Report) by 10.4% during the first quarter, Holdings...
Bullish
Johnson & Johnson (NYSE:JNJ) shares rose 1.2% on Monday, trading at $231.12, following an announcement of a more than $1 billion investment to expand ...
Bearish
A UK High Court has approved a Group Litigation Order for thousands of UK citizens diagnosed with mesothelioma and ovarian cancer, marking the largest...
Bullish
Johnson & Johnson (JNJ) has been given a "BUY" rating by 24/7 Wall St. with a price target of $261.72, suggesting an 11% upside. The bullish outlook i...
Neutral
Bayban bought a new position in Johnson & Johnson (NYSE:JNJ – Free Report) during the 4th quarter, according to its most recent Form 13F filing with t...
Neutral
AG Campbell Advisory LLC bought a new stake in Johnson & Johnson (NYSE:JNJ – Free Report) in the 4th quarter, according to its most recent 13F filing ...
Neutral
Auto Owners Insurance Co increased its position in shares of Johnson & Johnson (NYSE:JNJ – Free Report) by 22,225.6% during the 4th quarter, Holdings ...
Neutral
Corient Private Wealth LLC increased its holdings in shares of Johnson & Johnson (NYSE:JNJ – Free Report) by 4.9% during the fourth quarter, according...
Neutral
Tempo Wealth LLC bought a new position in shares of Johnson & Johnson (NYSE:JNJ – Free Report) in the 4th quarter, according to the company in its mos...